CERo Therapeutics Holdings, Inc. (CERO)

NASDAQ: CERO · IEX Real-Time Price · USD

1.500

-0.040 (-2.60%)

At close: Apr 19, 2024, 4:00 PM

1.480

-0.020 (-1.33%)

After-hours: Apr 19, 2024, 7:58 PM EDT

CERO Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021
Selling, General & Admin	2.89	2.84	2.48
Research & Development	0	0	9.14
Other Operating Expenses	0.04	0.06	0
Operating Expenses	2.93	2.91	11.62
Operating Income	-2.93	-2.91	-11.62
Other Expense / Income	-0.49	-2.84	-0.99
Pretax Income	-2.44	-0.07	-10.63
Income Tax	0.09	0.6	0
Net Income	-2.54	-0.67	-10.63
Shares Outstanding (Basic)	7	22	9
Shares Outstanding (Diluted)	7	22	9
Shares Change	-70.97%	150.43%	-
EPS (Basic)	-0.39	-0.03	-1.18
EPS (Diluted)	-0.39	-0.03	-1.18
Free Cash Flow	-1.52	-1.09	-10.71
Free Cash Flow Per Share	-0.23	-0.05	-1.19
EBITDA	-2.44	-0.07	-9.89
Depreciation & Amortization	0	0	0.74
EBIT	-2.44	-0.07	-10.63

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).